Daniel H Shu (Daniel Shu)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Smoking Cessation

Prognostic Factors

Top Venues

Cancer research communications

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie L Alden, Mir Lim, Chester Kao, Daniel H Shu, Amit G Singal, Anne M Noonan, Paige Griffith, Nilofer S Azad, Won Jin Ho, Ihab R Kamel, Mark Yarchoan, David Hsiehchen
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma. Cancer research communications 3 (7) (2023)
Daniel H Shu, Won Jin Ho, Luciane Tsukamoto Kagohara, Alexander A Girgis, Sarah M Shin, Ludmila V Danilova, Jae W Lee, Dimitrios N Sidiropoulos, Sarah Mitchell, Kabeer Munjal, Kathryn Howe, Kayla J Bendinelli, Hanfei Qi, Guanglan Mo, Janelle Montagne, James M Leatherman, Tamara Y Lopez-Vidal, Qingfeng Zhu, Amanda L Huff, Xuan Yuan, Alexei Hernandez, Erin M Coyne, Neeha Zaidi, Daniel J Zabransky, Logan L Engle, Aleksandra Ogurtsova, Nilofer S Azad, Daniel Laheru, Jennifer N Durham, Hao Wang, Robert Anders, Elizabeth D Thompson, Elana J Fertig, Mark Yarchoan
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade. bioRxiv : the preprint server for biology (2023)